Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
- PMID: 32557623
- PMCID: PMC7300950
- DOI: 10.1111/bjh.16896
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
Abstract
SARS-CoV-2 infection can cause severe pneumonia (COVID-19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In the present report, we first describe two cases of persisting SARS-CoV-2 viraemia with fatal outcome in patients after rituximab therapy.
Keywords: COVID-19; SARS-CoV-2; pneumonia; rituximab; viraemia.
© 2020 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
Figures
Comment in
-
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery.Br J Haematol. 2020 Aug;190(3):e154-e156. doi: 10.1111/bjh.16981. Epub 2020 Jul 16. Br J Haematol. 2020. PMID: 32593180 Free PMC article. No abstract available.
Similar articles
-
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery.Br J Haematol. 2020 Aug;190(3):e154-e156. doi: 10.1111/bjh.16981. Epub 2020 Jul 16. Br J Haematol. 2020. PMID: 32593180 Free PMC article. No abstract available.
-
COVID-19-related fatal myocarditis in a 42-year-old female patient.Cardiol J. 2020;27(5):642-643. doi: 10.5603/CJ.2020.0155. Cardiol J. 2020. PMID: 33165899 Free PMC article. No abstract available.
-
Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2).Int J Dermatol. 2020 Jul;59(7):874-875. doi: 10.1111/ijd.14919. Epub 2020 May 2. Int J Dermatol. 2020. PMID: 32358979 Free PMC article. No abstract available.
-
Potential pathogenesis of ageusia and anosmia in COVID-19 patients.Int Forum Allergy Rhinol. 2020 Sep;10(9):1103-1104. doi: 10.1002/alr.22593. Epub 2020 Jun 15. Int Forum Allergy Rhinol. 2020. PMID: 32342636 Free PMC article. Review. No abstract available.
-
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28. Neurol Sci. 2020. PMID: 32725449 Free PMC article. Review.
Cited by
-
Clinical Features and Prognosis of Patients with COVID-19 and B-Cell Non-Hodgkin Lymphoma.Infect Drug Resist. 2024 Oct 17;17:4501-4510. doi: 10.2147/IDR.S477107. eCollection 2024. Infect Drug Resist. 2024. PMID: 39435457 Free PMC article.
-
Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.Medicina (Kaunas). 2024 Aug 23;60(9):1377. doi: 10.3390/medicina60091377. Medicina (Kaunas). 2024. PMID: 39336418 Free PMC article.
-
Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies.Viruses. 2024 Jun 27;16(7):1040. doi: 10.3390/v16071040. Viruses. 2024. PMID: 39066203 Free PMC article.
-
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.Nat Commun. 2024 Mar 15;15(1):2360. doi: 10.1038/s41467-024-46673-2. Nat Commun. 2024. PMID: 38491050 Free PMC article.
-
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy.Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):723-734. doi: 10.1007/s10096-024-04776-0. Epub 2024 Feb 15. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38358552 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous